GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

SGLT2 inhibitors may be more cardioprotective for older adults, whereas GLP-1 receptor agonists may confer greater HbA1c reductions in that population. Image: Adobe Stock “Age should not be a ...

While all antihypertensive agents lower BP in African Americans, and simple regimens appear to work best at reducing cardiovascular outcomes, certain drug classes may have unique cardioprotective ...